Xylem's results for Q3 2026 (ended Sep 30, 2026) come from the company's own earnings release, filed with the SEC on 2026-10-27. Everything below is taken from that filing; quotes are copied exactly. Company outlooks are the company's own.
At a glance
| Item | Value |
|---|---|
| Revenue (GAAP) | $2,201 million (−3.0% vs a year earlier) |
| Diluted EPS (GAAP) | $1.25 |
| Adjusted per-share figure (company's non-GAAP measure; FFO/AFFO for REITs) | $1.44 |
| Full-year guidance | Lowered |
Guidance
Cut 2026 revenue outlook to about $8.95 billion (down 1%) and adjusted EPS to $5.40–$5.45 from $5.55–$5.70.
Why this label: Revenue now ~$8.95B (down 1%) 'versus prior guidance of up 2 percent'; adjusted EPS $5.40-5.45 'down from the previous guidance range of $5.55 to $5.70'.
| Metric | Period | New | Prior (as stated in the release) |
|---|---|---|---|
| revenue | FY2026 | ~$8.95 billion (down 1% reported; flat organic) | up 2% reported; up 2%–3% organic |
| adjusted EPS | FY2026 | $5.40–$5.45 | $5.55–$5.70 |
| free cash flow margin | FY2026 | ~10.2% | 10.2%–11.0% |
| adjusted EBITDA margin | FY2026 | ~23.2% (+100 bps vs 2025) | not stated |
From the release
Revenue: "Revenue · 2,201 · 2,268 · 6,662 · 6,638"
Earnings per share: "Earnings per share of $1.25, up 34%; $1.44 on an adjusted basis, up 5%"
revenue: "Xylem now forecasts full-year 2026 revenue of approximately $8.95 billion, down 1 percent year over year on a reported basis, versus prior guidance of up 2 percent, and flat on an organic basis, versus prior guidance of up 2 to 3 percent."
adjusted EPS: "This results in full-year adjusted earnings per share of $5.40 to $5.45, down from the previous guidance range of $5.55 to $5.70."
free cash flow margin: "Full-year free cash flow margin is expected to be approximately 10.2 percent, versus 10.2 to 11.0 percent previously guided."
Quotes are copied from the filing; in table rows, cell borders are shown as “·”.
Key fact: Lowered 2026 adjusted EPS guidance to $5.40–$5.45 from $5.55–$5.70.
Source
Xylem earnings release (SEC filing), accession 0001524472-26-000146, filed 2026-10-27.
Part of the Q3 2026 Guidance Tracker. Educational only, not advice. Free weekly recap every Sunday: yieldterminalpro.com/newsletter.